National institute of biomedical imaging and bioengineering (nibib) maternal health radx innovation funnel
Ended Awarded Last action
- Contract number
- 75N92022F00001
- Awardee
-
The General Hospital Corporation UEI FLJ7DQKLL226
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $399,558
Award facts
- Opportunity
-
- National Institute of Biomedical Imaging and Bioengineering (NIBIB) Innovation Pre-Solicitation · 75N92022R0114 · Posted May 26, 2022
- Contract value 100% obligated
- $399,558.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541614 Process, Physical Distribution, and Logistics Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Winter Hill, MA 02145, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $399,558 |
About this award
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a delivery order valued at $399,558.23 to Massachusetts General Hospital (MGH), a nonprofit academic medical center and teaching hospital of Harvard Medical School, on September 1, 2022. This firm fixed-price contract supports the NIBIB Maternal Health RadX Innovation Funnel initiative and will be performed at MGH's Winter Hill location in Boston, Massachusetts. The award was made without a set-aside designation, indicating competitive selection. The contract represents MGH's continued engagement as a major federal research partner, leveraging the institution's extensive capabilities in biomedical research and clinical innovation.
The delivery order is part of MGH's broader research portfolio with the National Heart Lung and Blood Institute (the funding federal agency) and other NIH components. MGH's research enterprise encompasses diverse scientific domains including maternal health, medical imaging technologies, and translational research initiatives that convert laboratory discoveries into clinical applications. The RadX Innovation Funnel program aligns with NIH's broader efforts to advance innovative biomedical solutions, and this award enables MGH to contribute specialized research and development services within that strategic initiative. The contract was completed by April 30, 2024.
Quick answers
Who was awarded contract 75N92022F00001?
75N92022F00001 was awarded to The General Hospital Corporation by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2022.
How much is contract 75N92022F00001 worth?
The government has obligated $399,558 on 75N92022F00001.
Is contract 75N92022F00001 an order under another contract?
Yes. 75N92022F00001 is a delivery order under 75N92022D00014, an indefinite delivery contract.
Was contract 75N92022F00001 competed?
The extent of competition for 75N92022F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award